CTXR

Citius Pharmaceuticals Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/16/2016
Contact Info
  • 11 Commerce Drive
  • 1st Floor
  • Cranford, NJ 01754

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001506251
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2010
Employees 5 a/o Aug 01, 2016
Company Officers/Contacts
Leonard Mazur Secretary
Myron Holubiak CEO, President
Company Directors
Leonard Mazur Executive Chairman
Company Notes
  • Formerly=Trail One, Inc. until 9-2014
Service Providers
Accounting/Auditing Firm
Wolf & Company, P.C.
99 High Street
Boston, MA, 02110
United States

Legal Counsel
Wyrick Robbins Yates & Ponton LLP
4101 Lake Boone Trail
Suite 300
Raleigh, NC, 27607
United States

Investor Relations Firm
Not Available
CTXR Security Details
Share Structure
Market Value1 $23,404,180 a/o Dec 06, 2016
Authorized Shares 90,000,000 a/o Nov 30, 2016
Outstanding Shares 73,138,061 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 28,666,895 a/o Aug 01, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 111 a/o Aug 01, 2016
Short Selling Data
Short Interest 5,558 (-31.48%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security